1.778.600.0509
Advancing the Paradigm of Patient Care

Investor
Centre

Annual General Meeting 

SEDAR FILINGS

Click the link below to view our SEDAR filings.

Stock Ticker

WEBINARS

Click the link below to view our archived webinars.

Investment Highlights

Large Addressable Global Markets

With NO efficient clinical solutions (unmet medical needs)

Novel Technologies

In the early identification of sepsis and treatment of biofilm infections

Extensive Intellectual Property

Portfolio of both Diagnostics and Therapeutics

Near-term Revenue Models

With multiple corporate partnership targets

Publicly-Listed

For enhanced shareholder liquidity

Experienced Management Team

With proven track records in med-tech and biopharma

ASEP and its subsidiaries' technologies have not received marketing authorization
and are not currently available for purchase
. © 2023 All Rights Reserved

CSE: ASEP | OTCQB: SEPSF | FSE: JJ8
This is default text for notification bar